Astrazeneca (AZN) closed the most recent trading day at $203.49, moving +1.37% from the previous trading session. This change outpaced the S&P 500's 0.11% gain on the day. Meanwhile, the Dow ...

Two years ago, the Emerald-1 trial hit its primary endpoint, showing that a cocktail of Imfinzi, Avastin and TACE reduced the ...

AstraZeneca has delivered a solid trailing 12 months, with shares up 31.43% over the past year, but the stock has pulled back nearly 5% over the past month.

AstraZeneca PLC (NYSE:AZN) is one of the 10 Top Stocks Fund Managers Are Loading Up On in 2026. On March 27, 2026, Deutsche ...

AstraZeneca PLC (NYSE:AZN) is one of the best pharma stocks to invest in now. AstraZeneca PLC (NYSE:AZN) received a rating ...

Astrazeneca (AZN) closed at $188.42 in the latest trading session, marking a +2.74% move from the prior day. The stock's change was more than the S&P 500's daily loss of 1.67%. Meanwhile, the Dow ...

AstraZeneca AZN is scheduled to report fourth-quarter and full-year 2025 results on Feb. 10, before the opening bell. In the last reported quarter, the company delivered an earnings surprise of 4.39% ...

A key question for ESO-T01 and other in vivo candidates will be the durability of their cancer eradication. While the ...

Ovarian Cancer Drugs Market · GlobeNewswire Inc. Dublin, March 31, 2026 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Market ...

Berenberg Bank analyst Luisa Hector maintained a Buy rating on AstraZeneca today and set a price target of £170.00. Claim 70% Off TipRanks Premium. Unlock hedge fund-level data a ...

The U.K. government is bringing together senior pharmaceutical executives to help chart a new direction for the country's drug-pricing system. Sky News reported that the group will analyze successors ...